{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:11:07Z","timestamp":1770484267013,"version":"3.49.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Syst Biol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Our study focuses on identifying potential biomarkers for diagnosis and early detection of ovarian cancer (OC) through the study of transcription regulation of genes affected by estrogen hormone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results are based on a set of 323 experimentally validated OC-associated genes compiled from several databases, and their subset controlled by estrogen. For these two gene sets we computationally determined transcription factors (TFs) that putatively regulate transcription initiation. We ranked these TFs based on the number of genes they are likely to control. In this way, we selected 17 top-ranked TFs as potential key regulators and thus possible biomarkers for a set of 323 OC-associated genes. For 77 estrogen controlled genes from this set we identified three unique TFs as potential biomarkers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>We introduced a new methodology to identify potential diagnostic biomarkers for OC. This report is the first bioinformatics study that explores multiple transcriptional regulators of OC-associated genes as potential diagnostic biomarkers in connection with estrogen responsiveness. We show that 64% of TF biomarkers identified in our study are validated based on real-time data from microarray expression studies. As an illustration, our method could identify CP2 that in combination with CA125 has been reported to be sensitive in diagnosing ovarian tumors.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1752-0509-5-144","type":"journal-article","created":{"date-parts":[[2011,9,20]],"date-time":"2011-09-20T08:44:21Z","timestamp":1316508261000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["In Silico discovery of transcription factors as potential diagnostic biomarkers of ovarian cancer"],"prefix":"10.1186","volume":"5","author":[{"given":"Mandeep","family":"Kaur","sequence":"first","affiliation":[]},{"given":"Cameron R","family":"MacPherson","sequence":"additional","affiliation":[]},{"given":"Sebastian","family":"Schmeier","sequence":"additional","affiliation":[]},{"given":"Kothandaraman","family":"Narasimhan","sequence":"additional","affiliation":[]},{"given":"Mahesh","family":"Choolani","sequence":"additional","affiliation":[]},{"given":"Vladimir B","family":"Bajic","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,9,19]]},"reference":[{"key":"749_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics, 2004. CA Cancer J Clin. 2004, 54: 8-29. 10.3322\/canjclin.54.1.8","journal-title":"CA Cancer J Clin"},{"key":"749_CR2","first-page":"502","volume":"3","author":"R Agarwal","year":"2003","unstructured":"Agarwal R, Kaye SB: Ovarian cancer: strategies for overcoming resistance to chemotherapy. NatRevCancer. 2003, 3: 502-516.","journal-title":"NatRevCancer"},{"key":"749_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2217\/bmm.09.21","volume":"3","author":"D Sasaroli","year":"2009","unstructured":"Sasaroli D, Coukos G, Scholler N: Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet?. Biomark Med. 2009, 3: 275-288. 10.2217\/bmm.09.21","journal-title":"Biomark Med"},{"key":"749_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2217\/17520363.2.3.291","volume":"2","author":"PM Das","year":"2008","unstructured":"Das PM, Bast RC: Early detection of ovarian cancer. Biomark Med. 2008, 2: 291-303. 10.2217\/17520363.2.3.291","journal-title":"Biomark Med"},{"key":"749_CR5","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1158\/1055-9965.EPI-10-0580","volume":"19","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Chan DW: The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers. Cancer Epidemiol Biomarkers Prev. 2010, 19: 2995-2999. 10.1158\/1055-9965.EPI-10-0580","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"749_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1471-2407-10-64","volume":"10","author":"N Kothandaraman","year":"2010","unstructured":"Kothandaraman N, Bajic V, Brendan P, Huak C, Keow P, Razvi K, Salto-Tellez M, Choolani M: E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer. BMC cancer. 2010, 10: 64- 10.1186\/1471-2407-10-64","journal-title":"BMC cancer"},{"key":"749_CR7","doi-asserted-by":"publisher","first-page":"e1000024","DOI":"10.1371\/journal.pmed.1000024","volume":"6","author":"A Crijns","year":"2009","unstructured":"Crijns A, Fehrmann R, De Jong S, Gerbens F, Meersma G, Klip H, Hollema H, Hofstra R, Te Meerman G, de Vries E: Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med. 2009, 6: e1000024-","journal-title":"PLoS Med"},{"key":"749_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/156652306775515501","volume":"6","author":"T Libermann","year":"2006","unstructured":"Libermann T, Zerbini L: Targeting transcription factors for cancer gene therapy. Current gene therapy. 2006, 6: 17-34. 10.2174\/156652306775515501","journal-title":"Current gene therapy"},{"key":"749_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1586\/14737140.8.1.33","volume":"8","author":"D Turner","year":"2008","unstructured":"Turner D, Watson D: ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Review of Anticancer Therapy. 2008, 8: 33-42. 10.1586\/14737140.8.1.33","journal-title":"Expert Review of Anticancer Therapy"},{"key":"749_CR10","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1158\/1078-0432.CCR-05-1847","volume":"12","author":"K Koyanagi","year":"2006","unstructured":"Koyanagi K, O'Day S, Gonzalez R, Lewis K, Robinson W, Amatruda T, Kuo C, Wang H, Milford R, Morton D: Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients. Clinical cancer research. 2006, 12: 1137- 10.1158\/1078-0432.CCR-05-1847","journal-title":"Clinical cancer research"},{"key":"749_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/annonc\/mdl287","volume":"17","author":"T Berghmans","year":"2006","unstructured":"Berghmans T, Paesmans M, Mascaux C, Martin B, Meert A, Haller A, Lafitte J, Sculier J: Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis. Annals of oncology. 2006, 17: 1673- 10.1093\/annonc\/mdl287","journal-title":"Annals of oncology"},{"key":"749_CR12","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.2174\/1381612054546699","volume":"11","author":"M Redell","year":"2005","unstructured":"Redell M, Tweardy D: Targeting transcription factors for cancer therapy. Current pharmaceutical design. 2005, 11: 2873-2887. 10.2174\/1381612054546699","journal-title":"Current pharmaceutical design"},{"key":"749_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/13547500701391353","volume":"12","author":"C Pipinikas","year":"2007","unstructured":"Pipinikas C, Nair S, FENSKE C: Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers. 2007, 12: 541-557. 10.1080\/13547500701391353","journal-title":"Biomarkers"},{"key":"749_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/13547500802591992","volume":"13","author":"CP Pipinikas","year":"2008","unstructured":"Pipinikas CP, Carter ND, Corbishley CM, Fenske CD: HIF-1alpha mRNA gene expression levels in improved diagnosis of early stages of prostate cancer. Biomarkers. 2008, 13: 680-691. 10.1080\/13547500802591992","journal-title":"Biomarkers"},{"key":"749_CR15","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.2001.81.3.1269","volume":"81","author":"A Aranda","year":"2001","unstructured":"Aranda A, Pascual A: Nuclear hormone receptors and gene expression. Physiol Rev. 2001, 81: 1269-1304.","journal-title":"Physiol Rev"},{"key":"749_CR16","volume-title":"IntJ GynecolPathol","author":"YT Jeon","year":"2008","unstructured":"Jeon YT, Kim YB, Park SY, Kim JW, Park NH, Kang SB, Song YS: Gonadotropin-releasing Hormone Receptor Expression in Endometrial Cancer. IntJ GynecolPathol. 2008,"},{"key":"749_CR17","volume-title":"Asian J Androl","author":"HL Mao","year":"2008","unstructured":"Mao HL, Zhu ZQ, Chen CD: The androgen receptor in hormone-refractory prostate cancer. Asian J Androl. 2008,"},{"key":"749_CR18","first-page":"1440","volume":"29","author":"WF Shi","year":"2008","unstructured":"Shi WF, Bartlett JS: Estrogen plays a critical role in AAV2-mediated gene transfer in ovarian cancer. Acta PharmacolSin. 2008, 29: 1440-1450.","journal-title":"Acta PharmacolSin"},{"key":"749_CR19","volume-title":"Cancer Sci","author":"F Suzuki","year":"2008","unstructured":"Suzuki F, Akahira JI, Miura I, Suzuki T, Ito K, Hayashi SI, Sasano H, Yaegashi N: Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 2008,"},{"key":"749_CR20","first-page":"461","volume":"106","author":"G Walker","year":"2007","unstructured":"Walker G, MacLeod K, Williams AR, Cameron DA, Smyth JF, Langdon SP: Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer. GynecolOncol. 2007, 106: 461-468.","journal-title":"GynecolOncol"},{"key":"749_CR21","first-page":"2233","volume":"8","author":"A Bowman","year":"2002","unstructured":"Bowman A, Gabra H, Langdon SP, Lessells A, Stewart M, Young A, Smyth JF: CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup. ClinCancer Res. 2002, 8: 2233-2239.","journal-title":"ClinCancer Res"},{"key":"749_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000077436","volume":"66","author":"CA Papadimitriou","year":"2004","unstructured":"Papadimitriou CA, Markaki S, Siapkaras J, Vlachos G, Efstathiou E, Grimani I, Hamilos G, Zorzou M, Dimopoulos MA: Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II study. Oncology. 2004, 66: 112-117. 10.1159\/000077436","journal-title":"Oncology"},{"key":"749_CR23","first-page":"3617","volume":"13","author":"JF Smyth","year":"2007","unstructured":"Smyth JF, Gourley C, Walker G, MacKean MJ, Stevenson A, Williams AR, Nafussi AA, Rye T, Rye R, Stewart M, et al.: Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patients. ClinCancer Res. 2007, 13: 3617-3622.","journal-title":"ClinCancer Res"},{"key":"749_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jama.288.3.334","volume":"288","author":"JV Lacey Jr","year":"2002","unstructured":"Lacey JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C: Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002, 288: 334-341. 10.1001\/jama.288.3.334","journal-title":"JAMA"},{"key":"749_CR25","first-page":"367","volume":"10","author":"A Garcia-Velasco","year":"2008","unstructured":"Garcia-Velasco A, Mendiola C, Sanchez-Munoz A, Ballestin C, Colomer R, Cortes-Funes H: Prognostic value of hormonal receptors, p53, ki67 and HER2\/neu expression in epithelial ovarian carcinoma. ClinTranslOncol. 2008, 10: 367-371.","journal-title":"ClinTranslOncol"},{"key":"749_CR26","first-page":"148","volume":"630","author":"AH Eliassen","year":"2008","unstructured":"Eliassen AH, Hankinson SE: Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. AdvExpMedBiol. 2008, 630: 148-165.","journal-title":"AdvExpMedBiol"},{"key":"749_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1515\/BC.2003.037","volume":"384","author":"G Musumarra","year":"2003","unstructured":"Musumarra G, Barresi V, Condorelli DF, Scire S: A bioinformatic approach to the identification of candidate genes for the development of new cancer diagnostics. Biol Chem. 2003, 384: 321-327. 10.1515\/BC.2003.037","journal-title":"Biol Chem"},{"key":"749_CR28","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/1471-2164-9-481","volume":"9","author":"M Kaur","year":"2008","unstructured":"Kaur M, Schmeier S, Macpherson CR, Hofmann O, Hide WA, Taylor S, Willcox N, Bajic VB: Prioritizing genes of potential relevance to diseases affected by sex hormones: an example of Myasthenia Gravis. BMC Genomics. 2008, 9: 481- 10.1186\/1471-2164-9-481","journal-title":"BMC Genomics"},{"key":"749_CR29","first-page":"3245","volume":"12","author":"Y Kun","year":"2003","unstructured":"Kun Y, How LC, Hoon TP, Bajic VB, Lam TS, Aggarwal A, Sze HG, Bok WS, Yin WC, Tan P: Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor. HumMolGenet. 2003, 12: 3245-3258.","journal-title":"HumMolGenet"},{"key":"749_CR30","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/gb-2004-5-9-r66","volume":"5","author":"CY Lin","year":"2004","unstructured":"Lin CY, Strom A, Vega VB, Kong SL, Yeo AL, Thomsen JS, Chan WC, Doray B, Bangarusamy DK, Ramasamy A, et al.: Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol. 2004, 5: R66- 10.1186\/gb-2004-5-9-r66","journal-title":"Genome Biol"},{"key":"749_CR31","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1093\/nar\/gkh943","volume":"32","author":"S Tang","year":"2004","unstructured":"Tang S, Tan SL, Ramadoss SK, Kumar AP, Tang MH, Bajic VB: Computational method for discovery of estrogen responsive genes. Nucleic Acids Res. 2004, 32: 6212-6217. 10.1093\/nar\/gkh943","journal-title":"Nucleic Acids Res"},{"key":"749_CR32","doi-asserted-by":"publisher","first-page":"D732","DOI":"10.1093\/nar\/gkl816","volume":"35","author":"S Tang","year":"2007","unstructured":"Tang S, Zhang Z, Tan SL, Tang MH, Kumar AP, Ramadoss SK, Bajic VB: KBERG: KnowledgeBase for Estrogen Responsive Genes. Nucleic Acids Res. 2007, 35: D732-D736. 10.1093\/nar\/gkl816","journal-title":"Nucleic Acids Res"},{"key":"749_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1677\/jme.1.01839","volume":"35","author":"VX Jin","year":"2005","unstructured":"Jin VX, Sun H, Pohar TT, Liyanarachchi S, Palaniswamy SK, Huang TH, Davuluri RV: ERTargetDB: an integral information resource of transcription regulation of estrogen receptor target genes. J MolEndocrinol. 2005, 35: 225-230.","journal-title":"J MolEndocrinol"},{"key":"749_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0022-4731(89)90062-9","volume":"34","author":"W Wahli","year":"1989","unstructured":"Wahli W, Martinez E, Cort'esy B, Cardinaux J: cis-and trans-acting elements of the estrogen-regulated vitellogenin gene B1 of Xenopus laevis. Journal of steroid biochemistry. 1989, 34: 17-32. 10.1016\/0022-4731(89)90062-9","journal-title":"Journal of steroid biochemistry"},{"key":"749_CR35","first-page":"1289","volume":"38","author":"JS Carroll","year":"2006","unstructured":"Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, et al.: Genome-wide analysis of estrogen receptor binding sites. NatGenet. 2006, 38: 1289-1297.","journal-title":"NatGenet"},{"key":"749_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0303-7207(98)00090-2","volume":"141","author":"D Marilley","year":"1998","unstructured":"Marilley D, Robyr D, Schild-Poulter C, Wahli W: Regulation of the vitellogenin gene B1 promoter after transfer into hepatocytes in primary cultures. Molecular and cellular endocrinology. 1998, 141: 79-93. 10.1016\/S0303-7207(98)00090-2","journal-title":"Molecular and cellular endocrinology"},{"key":"749_CR37","first-page":"556","volume":"129","author":"G Sica","year":"2008","unstructured":"Sica G, Vazquez MF, Altorki N, Port J, Lee PC, Liu Y, Hyjek E, Saqi A: PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens. AmJ ClinPathol. 2008, 129: 556-562.","journal-title":"AmJ ClinPathol"},{"key":"749_CR38","first-page":"871","volume":"20","author":"KC Jensen","year":"2007","unstructured":"Jensen KC, Higgins JP, Montgomery K, Kaygusuz G, van de RM, Natkunam Y: The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. ModPathol. 2007, 20: 871-877.","journal-title":"ModPathol"},{"key":"749_CR39","first-page":"277","volume":"83","author":"MJ Provenzano","year":"2007","unstructured":"Provenzano MJ, Yu L, Hitchler MJ, Fitzgerald MP, Robinson RA, Wayne S, Ver MM, Domann FE: AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma. ExpMolPathol. 2007, 83: 277-282.","journal-title":"ExpMolPathol"},{"key":"749_CR40","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ijc.21426","volume":"118","author":"M Li","year":"2006","unstructured":"Li M, Wang Y, Hung MC, Kannan P: Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2\/neu gene in breast cancer. IntJ Cancer. 2006, 118: 802-811. 10.1002\/ijc.21426.","journal-title":"IntJ Cancer"},{"key":"749_CR41","first-page":"83","volume":"12","author":"MA Bidus","year":"2006","unstructured":"Bidus MA, Risinger JI, Chandramouli GV, Dainty LA, Litzi TJ, Berchuck A, Barrett JC, Maxwell GL: Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray. ClinCancer Res. 2006, 12: 83-88.","journal-title":"ClinCancer Res"},{"key":"749_CR42","first-page":"284","volume":"33","author":"J Feng","year":"1998","unstructured":"Feng J, Qian H, Tian Y: [Application of multi-tumor markers in ovarian carcinoma]. Zhonghua Fu Chan KeZa Zhi. 1998, 33: 284-286.","journal-title":"Zhonghua Fu Chan KeZa Zhi"},{"key":"749_CR43","first-page":"5","volume":"43","author":"L Dong","year":"2008","unstructured":"Dong L, Cui H, Li XP, Sun LF, Chang XH, Liang XD, Zhu HL: Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients. Zhonghua Fu Chan KeZa Zhi. 2008, 43: 5-8.","journal-title":"Zhonghua Fu Chan KeZa Zhi"},{"key":"749_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ygyno.2010.03.020","volume":"118","author":"S Previdi","year":"2010","unstructured":"Previdi S, Malek A, Albertini V, Riva C, Capella C, Broggini M, Carbone GM, Rohr J, Catapano CV: Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts. Gynecol Oncol. 2010, 118: 182-188. 10.1016\/j.ygyno.2010.03.020","journal-title":"Gynecol Oncol"},{"key":"749_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1677\/JME-07-0043","volume":"39","author":"S Khan","year":"2007","unstructured":"Khan S, Wu F, Liu S, Wu Q, Safe S: Role of specificity protein transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells. J MolEndocrinol. 2007, 39: 289-304.","journal-title":"J MolEndocrinol"},{"key":"749_CR46","first-page":"87","volume":"39","author":"B Davidson","year":"2008","unstructured":"Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M, Risberg B, Florenes VA, Kopolovic J, Reich R: Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. HumPathol. 2008, 39: 87-95.","journal-title":"HumPathol"},{"key":"749_CR47","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1074\/jbc.272.29.18250","volume":"272","author":"dM Batistuzzo","year":"1997","unstructured":"Batistuzzo dM, Krey G, Hihi AK, Wahli W: Functional interactions between the estrogen receptor and the transcription activator Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 io promoter. J Biol Chem. 1997, 272: 18250-18260. 10.1074\/jbc.272.29.18250","journal-title":"J Biol Chem"},{"key":"749_CR48","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","volume":"98","author":"JB Welsh","year":"2001","unstructured":"Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM: Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci USA. 2001, 98: 1176-1181. 10.1073\/pnas.98.3.1176","journal-title":"Proc Natl Acad Sci USA"},{"key":"749_CR49","doi-asserted-by":"publisher","first-page":"D542","DOI":"10.1093\/nar\/gkh107","volume":"32","author":"V Praz","year":"2004","unstructured":"Praz V, Jagannathan V, Bucher P: CleanEx: a database of heterogeneous gene expression data based on a consistent gene nomenclature. Nucleic Acids Res. 2004, 32: D542-547. 10.1093\/nar\/gkh107","journal-title":"Nucleic Acids Res"},{"key":"749_CR50","first-page":"7388","volume":"61","author":"AI Su","year":"2001","unstructured":"Su AI, Welsh JB, Sapinoso LM, Kern SG, Dimitrov P, Lapp H, Schultz PG, Powell SM, Moskaluk CA, Frierson HF, Hampton GM: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 2001, 61: 7388-7393.","journal-title":"Cancer Res"},{"key":"749_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"D Rhodes","year":"2004","unstructured":"Rhodes D, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan A: ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (New York, NY). 2004, 6: 1-","journal-title":"Neoplasia (New York, NY)"},{"key":"749_CR52","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/sj.bjc.6601603","volume":"90","author":"TR Adib","year":"2004","unstructured":"Adib TR, Henderson S, Perrett C, Hewitt D, Bourmpoulia D, Ledermann J, Boshoff C: Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer. 2004, 90: 686-692. 10.1038\/sj.bjc.6601603","journal-title":"Br J Cancer"},{"key":"749_CR53","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/0008-5472.CAN-05-3694","volume":"66","author":"ND Hendrix","year":"2006","unstructured":"Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR: Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 2006, 66: 1354-1362. 10.1158\/0008-5472.CAN-05-3694","journal-title":"Cancer Res"},{"key":"749_CR54","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","volume":"10","author":"KH Lu","year":"2004","unstructured":"Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, Ramoth LR, Rosen DG, Liu J, Hellstrom I, et al.: Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res. 2004, 10: 3291-3300. 10.1158\/1078-0432.CCR-03-0409","journal-title":"Clin Cancer Res"},{"key":"749_CR55","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood.V82.4.1300.1300","volume":"82","author":"M Kreutz","year":"1993","unstructured":"Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H: 1, 25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood. 1993, 82: 1300-1307.","journal-title":"Blood"},{"key":"749_CR56","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/13547500701391353","volume":"12","author":"CP Pipinikas","year":"2007","unstructured":"Pipinikas CP, Nair SB, Kirby RS, Carter ND, Fenske CD: Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study. Biomarkers. 2007, 12: 541-557. 10.1080\/13547500701391353","journal-title":"Biomarkers"},{"key":"749_CR57","volume-title":"J Psychiatr Res","author":"R Belzeaux","year":"2010","unstructured":"Belzeaux R, Formisano-Treziny C, Loundou A, Boyer L, Gabert J, Samuelian JC, Feron F, Naudin J, Ibrahim EC: Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression. J Psychiatr Res. 2010,"},{"key":"749_CR58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1196\/annals.1378.073","volume":"1091","author":"D Reimer","year":"2006","unstructured":"Reimer D, Sadr S, Wiedemair A, Goebel G, Concin N, Hofstetter G, Marth C, Zeimet AG: Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer. Ann N Y Acad Sci. 2006, 1091: 270-281. 10.1196\/annals.1378.073","journal-title":"Ann N Y Acad Sci"},{"key":"749_CR59","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/73536","volume":"24","author":"S Gayther","year":"2000","unstructured":"Gayther S, Batley S, Linger L, Bannister A, Thorpe K, Chin S, Daigo Y, Russell P, Wilson A, Sowter H: Mutations truncating the EP300 acetylase in human cancers. Nature genetics. 2000, 24: 300-303. 10.1038\/73536","journal-title":"Nature genetics"},{"key":"749_CR60","first-page":"239","volume":"164","author":"M Friedrich","year":"2003","unstructured":"Friedrich M, Rafi L, Mitschele T, Tilgen W, Schmidt W, Reichrath J: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer. Recent results in cancer research Fortschritte der Krebsforschung Progr\u00e8s dans les recherches sur le cancer. 2003, 164: 239-","journal-title":"Recent results in cancer research Fortschritte der Krebsforschung Progr\u00e8s dans les recherches sur le cancer"},{"key":"749_CR61","volume-title":"British journal of cancer","author":"S Tamez","year":"2009","unstructured":"Tamez S, Norizoe C, Ochiai K, Takahashi D, Shimojima A, Tsutsumi Y, Yanaihara N, Tanaka T, Okamoto A, Urashima M: Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. British journal of cancer. 2009,"},{"key":"749_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2353\/jmoldx.2009.080072","volume":"11","author":"A Melnikov","year":"2009","unstructured":"Melnikov A, Scholtens D, Godwin A, Levenson V: Differential methylation profile of ovarian cancer in tissues and plasma. Journal of Molecular Diagnostics. 2009, 11: 60- 10.2353\/jmoldx.2009.080072","journal-title":"Journal of Molecular Diagnostics"},{"key":"749_CR63","doi-asserted-by":"publisher","first-page":"11961","DOI":"10.1074\/jbc.M411985200","volume":"280","author":"L Bourguignon","year":"2005","unstructured":"Bourguignon L, Gilad E, Rothman K, Peyrollier K: Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1\/estrogen receptor transcriptional activation, and ovarian cancer progression. Journal of Biological Chemistry. 2005, 280: 11961- 10.1074\/jbc.M411985200","journal-title":"Journal of Biological Chemistry"},{"key":"749_CR64","volume-title":"Nucleic Acids Res","author":"M Kaur","year":"2008","unstructured":"Kaur M, Radovanovic A, Essack M, Schaefer U, Maqungo M, Kibler T, Schmeier S, Christoffels A, Narasimhan K, Choolani M, Bajic VB: Database for exploration of functional context of genes implicated in ovarian cancer. Nucleic Acids Res. 2008,"},{"key":"749_CR65","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/nar\/gkg108","volume":"31","author":"V Matys","year":"2003","unstructured":"Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, et al.: TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003, 31: 374-378. 10.1093\/nar\/gkg108","journal-title":"Nucleic Acids Res"},{"key":"749_CR66","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1093\/nar\/gkg585","volume":"31","author":"AE Kel","year":"2003","unstructured":"Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E: MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res. 2003, 31: 3576-3579. 10.1093\/nar\/gkg585","journal-title":"Nucleic Acids Res"},{"key":"749_CR67","first-page":"177","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR: A census of human cancer genes. NatRevCancer. 2004, 4: 177-183.","journal-title":"NatRevCancer"},{"key":"749_CR68","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/bioinformatics\/18.11.1542","volume":"18","author":"M Safran","year":"2002","unstructured":"Safran M, Solomon I, Shmueli O, Lapidot M, Shen-Orr S, Adato A, Ben Dor U, Esterman N, Rosen N, Peter I, et al.: GeneCards 2002: towards a complete, object-oriented, human gene compendium. Bioinformatics. 2002, 18: 1542-1543. 10.1093\/bioinformatics\/18.11.1542","journal-title":"Bioinformatics"},{"key":"749_CR69","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al.: A gene atlas of the mouse and human protein-encoding transcriptomes. ProcNatlAcadSci USA. 2004, 101: 6062-6067. 10.1073\/pnas.0400782101.","journal-title":"ProcNatlAcadSci USA"},{"key":"749_CR70","volume-title":"CurrProtocHumGenet","author":"AD Baxevanis","year":"2003","unstructured":"Baxevanis AD: Searching Online Mendelian Inheritance in Man (OMIM) for information for genetic loci involved in human disease. CurrProtocHumGenet. 2003, Chapter 9: Unit9,"},{"key":"749_CR71","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1210\/en.141.9.3052","volume":"141","author":"CP Leo","year":"2000","unstructured":"Leo CP, Vitt UA, Hsueh AJ: The Ovarian Kaleidoscope database: an online resource for the ovarian research community. Endocrinology. 2000, 141: 3052-3054. 10.1210\/en.141.9.3052","journal-title":"Endocrinology"},{"key":"749_CR72","doi-asserted-by":"publisher","first-page":"D26","DOI":"10.1093\/nar\/gkl993","volume":"35","author":"D Maglott","year":"2007","unstructured":"Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2007, 35: D26-D31. 10.1093\/nar\/gkl993","journal-title":"Nucleic Acids Res"},{"key":"749_CR73","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0764-4469(99)80021-3","volume":"321","author":"J Frezal","year":"1998","unstructured":"Frezal J: Genatlas database, genes and development defects. C RAcadSci III. 1998, 321: 805-817. 10.1016\/S0764-4469(99)80021-3.","journal-title":"C RAcadSci III"},{"key":"749_CR74","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1112014","volume":"309","author":"P Carninci","year":"2005","unstructured":"Carninci P, Kasukawa T, Katayama S, Gough J, Frith MC, Maeda N, Oyama R, Ravasi T, Lenhard B, Wells C, et al.: The transcriptional landscape of the mammalian genome. Science. 2005, 309: 1559-1563.","journal-title":"Science"},{"key":"749_CR75","first-page":"626","volume":"38","author":"P Carninci","year":"2006","unstructured":"Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA, Taylor MS, Engstrom PG, Frith MC, et al.: Genome-wide analysis of mammalian promoter architecture and evolution. NatGenet. 2006, 38: 626-635.","journal-title":"NatGenet"},{"key":"749_CR76","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1093\/nar\/gkg517","volume":"31","author":"VB Bajic","year":"2003","unstructured":"Bajic VB, Tan SL, Chong A, Tang S, Strom A, Gustafsson JA, Lin CY, Liu ET: Dragon ERE Finder version 2: A tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Res. 2003, 31: 3605-3607. 10.1093\/nar\/gkg517","journal-title":"Nucleic Acids Res"},{"key":"749_CR77","first-page":"109","volume":"4","author":"VB Bajic","year":"2004","unstructured":"Bajic VB, Choudhary V, Hock CK: Content analysis of the core promoter region of human genes. In SilicoBiol. 2004, 4: 109-125.","journal-title":"In SilicoBiol"},{"key":"749_CR78","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1371\/journal.pgen.0020054","volume":"2","author":"VB Bajic","year":"2006","unstructured":"Bajic VB, Tan SL, Christoffels A, Sch\u00f6nbach C, Lipovich L, Yang L, Hofmann O, Kruger A, Hide W, Kai C, et al.: Mice and Men: Their Promoter Properties. PLoS Genet. 2006, 2: e54- 10.1371\/journal.pgen.0020054","journal-title":"PLoS Genet"},{"key":"749_CR79","first-page":"25","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al.: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. NatGenet. 2000, 25: 25-29.","journal-title":"NatGenet"},{"key":"749_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4: 3-10.1186\/gb-2003-4-5-p3.","journal-title":"Genome Biol"},{"key":"749_CR81","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093\/nar\/28.1.27","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Systems Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-0509-5-144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:48:33Z","timestamp":1630514913000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsystbiol.biomedcentral.com\/articles\/10.1186\/1752-0509-5-144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,19]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1186\/1752-0509-5-144","relation":{},"ISSN":["1752-0509"],"issn-type":[{"value":"1752-0509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,19]]},"assertion":[{"value":"16 April 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"144"}}